Stocks
Anixa Biosciences, Inc.ANIX
NASDAQHealthcareBiotechnology$2.65
A clinical-stage biotechnology company developing immunotherapy-based treatments and vaccines for cancer, with programs targeting ovarian and breast cancers as well as CAR-T therapies. Its pipeline includes collaborations with academic institutions such as the Cleveland Clinic to advance novel immun...
52W Range: $2.33 – $5.46
Congressional Interest in Anixa Biosciences, Inc. (ANIX)
1 member of Congress has disclosed 2 trades in Anixa Biosciences, Inc. (ANIX), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
1
Buys
2
Sells
0
Who in Congress Is Trading ANIX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2016-01-14 | JAMES B. RENACCI | buy | $15K – $50K |
| 2015-12-09 | JAMES B. RENACCI | buy | $15K – $50K |